We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mallinckrodt Evaluates Nitric Oxide as COVID-19 Treatment
Mallinckrodt Evaluates Nitric Oxide as COVID-19 Treatment
Mallinckrodt has launched a retrospective study to collect real-world data on its nitric gas inhaled therapy, INOmax, as a potential treatment for COVID-19 patients with respiratory problems.